Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 1, 1993
[Assessment of the quality of life of prostate cancer patients]S Isaka, J Shimazaki, H Akaza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for AdriamycinT Kotake, H Akaza, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1988
[Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer]T Niijima, Y Aso, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer]Y Aso, H Akaza, K Koiso, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Antiemetic effects of MS-5080 associated with cisplatin chemotherapy--an attempt in assessment based on the sample score system using multivariate analysis]T Niijima, Y Aso, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1987
[Response criteria for prostatic cancer treated by chemotherapy or antiandrogenic therapy]H Akaza, M Usami, T Kotake, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1990
[Histological effects of endocrine therapy on prostatic cancer]S Isaka, K Akakura, J Shimazaki, et al.
European Urology|August 15, 2000
Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinomaT Shimazui, J Oosterwijk-Wakka, H Akaza, et al.
Japanese Journal of Cancer Research : Gann|June 11, 1999
Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 ratsM Onozawa, T Kawamori, M Baba, et al.
Japanese Journal of Pharmacology|April 15, 1999
YM116, 2-(1H-imidazol-4-ylmethyl)-9H-carbazole, decreases adrenal androgen synthesis by inhibiting C17-20 lyase activity in NCI-H295 human adrenocortical carcinoma cellsY Ideyama, M Kudoh, K Tanimoto, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 1, 1993
[Assessment of the quality of life of prostate cancer patients]S Isaka, J Shimazaki, H Akaza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for AdriamycinT Kotake, H Akaza, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1988
[Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer]T Niijima, Y Aso, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer]Y Aso, H Akaza, K Koiso, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1987
[Antiemetic effects of MS-5080 associated with cisplatin chemotherapy--an attempt in assessment based on the sample score system using multivariate analysis]T Niijima, Y Aso, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1987
[Response criteria for prostatic cancer treated by chemotherapy or antiandrogenic therapy]H Akaza, M Usami, T Kotake, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1990
[Histological effects of endocrine therapy on prostatic cancer]S Isaka, K Akakura, J Shimazaki, et al.
European Urology|August 15, 2000
Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinomaT Shimazui, J Oosterwijk-Wakka, H Akaza, et al.
Japanese Journal of Cancer Research : Gann|June 11, 1999
Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 ratsM Onozawa, T Kawamori, M Baba, et al.
Japanese Journal of Pharmacology|April 15, 1999
YM116, 2-(1H-imidazol-4-ylmethyl)-9H-carbazole, decreases adrenal androgen synthesis by inhibiting C17-20 lyase activity in NCI-H295 human adrenocortical carcinoma cellsY Ideyama, M Kudoh, K Tanimoto, et al.
Pageof 30